These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Transgenic expression of IL-33 activates CD8(+) T cells and NK cells and inhibits tumor growth and metastasis in mice. Gao K; Li X; Zhang L; Bai L; Dong W; Gao K; Shi G; Xia X; Wu L; Zhang L Cancer Lett; 2013 Jul; 335(2):463-71. PubMed ID: 23499895 [TBL] [Abstract][Full Text] [Related]
25. NLRP3 suppresses NK cell-mediated responses to carcinogen-induced tumors and metastases. Chow MT; Sceneay J; Paget C; Wong CS; Duret H; Tschopp J; Möller A; Smyth MJ Cancer Res; 2012 Nov; 72(22):5721-32. PubMed ID: 22986739 [TBL] [Abstract][Full Text] [Related]
26. Frequency, suppressive capacity, recruitment and induction mechanisms of regulatory T cells in sinonasal squamous cell carcinoma and nasal inverted papilloma. Lou H; Fang J; Li P; Zhou W; Wang Y; Fan E; Li Y; Wang H; Liu Z; Xiao L; Wang C; Zhang L PLoS One; 2015; 10(5):e0126463. PubMed ID: 26020249 [TBL] [Abstract][Full Text] [Related]
27. Synergistic effect of regulatory T cells and proinflammatory cytokines in angiogenesis in the endometriotic milieu. Wang XQ; Zhou WJ; Luo XZ; Tao Y; Li DJ Hum Reprod; 2017 Jun; 32(6):1304-1317. PubMed ID: 28383711 [TBL] [Abstract][Full Text] [Related]
28. Umbilical cord blood‑derived Helios‑positive regulatory T cells promote angiogenesis in acute lymphoblastic leukemia in mice via CCL22 and the VEGFA‑VEGFR2 pathway. Li X; Li D; Shi Q; Huang X; Ju X Mol Med Rep; 2019 May; 19(5):4195-4204. PubMed ID: 30896872 [TBL] [Abstract][Full Text] [Related]
29. Targeting the Dendritic Cell-Secreted Immunoregulatory Cytokine CCL22 Alleviates Radioresistance. Bugno J; Wang L; Yu X; Cao X; Wang J; Huang X; Yang K; Piffko A; Chen K; Luo SY; Naccasha E; Hou Y; Fu S; He C; Fu YX; Liang HL; Weichselbaum RR Clin Cancer Res; 2024 Oct; 30(19):4450-4463. PubMed ID: 38691100 [TBL] [Abstract][Full Text] [Related]
30. Macrophage-derived CCL22 promotes an immunosuppressive tumor microenvironment via IL-8 in malignant pleural effusion. Wang D; Yang L; Yue D; Cao L; Li L; Wang D; Ping Y; Shen Z; Zheng Y; Wang L; Zhang Y Cancer Lett; 2019 Jun; 452():244-253. PubMed ID: 30928379 [TBL] [Abstract][Full Text] [Related]
31. Tumor microenvironmental conversion of natural killer cells into myeloid-derived suppressor cells. Park YJ; Song B; Kim YS; Kim EK; Lee JM; Lee GE; Kim JO; Kim YJ; Chang WS; Kang CY Cancer Res; 2013 Sep; 73(18):5669-81. PubMed ID: 23867469 [TBL] [Abstract][Full Text] [Related]
32. Suppression of intratumoral CCL22 by type i interferon inhibits migration of regulatory T cells and blocks cancer progression. Anz D; Rapp M; Eiber S; Koelzer VH; Thaler R; Haubner S; Knott M; Nagel S; Golic M; Wiedemann GM; Bauernfeind F; Wurzenberger C; Hornung V; Scholz C; Mayr D; Rothenfusser S; Endres S; Bourquin C Cancer Res; 2015 Nov; 75(21):4483-93. PubMed ID: 26432403 [TBL] [Abstract][Full Text] [Related]
33. Tumors skew endothelial cells to disrupt NK cell, T-cell and macrophage functions. Mulligan JK; Lathers DM; Young MR Cancer Immunol Immunother; 2008 Jul; 57(7):951-61. PubMed ID: 18058097 [TBL] [Abstract][Full Text] [Related]
34. IL-4/CCL22/CCR4 axis controls regulatory T-cell migration that suppresses inflammatory bone loss in murine experimental periodontitis. Araujo-Pires AC; Vieira AE; Francisconi CF; Biguetti CC; Glowacki A; Yoshizawa S; Campanelli AP; Trombone AP; Sfeir CS; Little SR; Garlet GP J Bone Miner Res; 2015 Mar; 30(3):412-22. PubMed ID: 25264308 [TBL] [Abstract][Full Text] [Related]
35. Gene therapy for murine lung cancer using an adenoviral vector expressing interleukin-15. Yoshimuta T Kurume Med J; 2004; 51(3-4):225-33. PubMed ID: 15682829 [TBL] [Abstract][Full Text] [Related]
36. Cutting edge: the Idd3 genetic interval determines regulatory T cell function through CD11b+CD11c- APC. Anderson AC; Chandwaskar R; Lee DH; Kuchroo VK J Immunol; 2008 Dec; 181(11):7449-52. PubMed ID: 19017931 [TBL] [Abstract][Full Text] [Related]
37. Cancer-associated fibroblast-derived interleukin-1β activates protumor C-C motif chemokine ligand 22 signaling in head and neck cancer. Huang YH; Chang CY; Kuo YZ; Fang WY; Kao HY; Tsai ST; Wu LW Cancer Sci; 2019 Sep; 110(9):2783-2793. PubMed ID: 31325403 [TBL] [Abstract][Full Text] [Related]
38. Skin melanoma development in ret transgenic mice despite the depletion of CD25+Foxp3+ regulatory T cells in lymphoid organs. Kimpfler S; Sevko A; Ring S; Falk C; Osen W; Frank K; Kato M; Mahnke K; Schadendorf D; Umansky V J Immunol; 2009 Nov; 183(10):6330-7. PubMed ID: 19841169 [TBL] [Abstract][Full Text] [Related]
39. Chemoattraction, adhesion and activation of natural killer cells are involved in the antitumor immune response induced by fractalkine/CX3CL1. Guo J; Chen T; Wang B; Zhang M; An H; Guo Z; Yu Y; Qin Z; Cao X Immunol Lett; 2003 Oct; 89(1):1-7. PubMed ID: 12946858 [TBL] [Abstract][Full Text] [Related]
40. Myeloid-derived suppressor cells depletion may cause pregnancy loss via upregulating the cytotoxicity of decidual natural killer cells. Ren J; Zeng W; Tian F; Zhang S; Wu F; Qin X; Zhang Y; Lin Y Am J Reprod Immunol; 2019 Apr; 81(4):e13099. PubMed ID: 30737988 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]